Donald Notman's most recent trade in Ocular Therapeutix Inc was a trade of 344,115 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ocular Therapeutix Inc | Donald Notman | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 344,115 | 344,115 | - | - | Stock Option (Right to Buy) | |
| Ocular Therapeutix Inc | Donald Notman | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 115,000 | 308,444 (0%) | 0% | 0 | Common Stock | |
| Ocular Therapeutix Inc | Donald Notman | See Remarks | Sale of securities on an exchange or to another person at price $ 7.81 per share. | 31 Jan 2025 | 11,119 | 193,444 (0%) | 0% | 7.8 | 86,839 | Common Stock |
| Ocular Therapeutix Inc | Donald Notman | See Remarks | Sale of securities on an exchange or to another person at price $ 7.84 per share. | 31 Jan 2025 | 6,301 | 204,563 (0%) | 0% | 7.8 | 49,400 | Common Stock |
| Ocular Therapeutix Inc | Donald Notman | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2024 | 33,602 | 33,602 | - | - | Stock Option (Right to Buy) | |
| Ocular Therapeutix Inc | Donald Notman | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2024 | 11,034 | 208,988 (0%) | 0% | 0 | Common Stock | |
| Ocular Therapeutix Inc | Donald Notman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2024 | 185,000 | 185,000 | - | - | Stock Option (Right to Buy) | |
| Ocular Therapeutix Inc | Donald Notman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2024 | 61,636 | 201,568 (0%) | 0% | 0 | Common Stock | |
| Ocular Therapeutix Inc | Notman Donald | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 4.86 per share. | 03 Feb 2024 | 6,212 | 195,356 (0%) | 0% | 4.9 | 30,190 | Common Stock |
| Ocular Therapeutix Inc | Notman Donald | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 4.95 per share. | 31 Jan 2024 | 6,433 | 139,932 (0%) | 0% | 4.9 | 31,843 | Common Stock |
| Ocular Therapeutix Inc | Donald Notman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 4.24 per share. | 06 Feb 2023 | 6,476 | 139,387 (0%) | 0% | 4.2 | 27,458 | Common Stock |
| Ocular Therapeutix Inc | Donald Notman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2023 | 166,667 | 166,667 | - | - | Stock Option (Right to Buy) | |
| Ocular Therapeutix Inc | Donald Notman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2023 | 55,556 | 145,863 (0%) | 0% | 0 | Common Stock | |
| Ocular Therapeutix Inc | Donald Notman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2022 | 166,667 | 166,667 | - | - | Stock Option (Right to Buy) | |
| Ocular Therapeutix Inc | Donald Notman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2022 | 55,556 | 81,632 (0%) | 0% | 0 | Common Stock | |
| Ocular Therapeutix Inc | Donald Notman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 190,000 | 190,000 | - | - | Stock Option (Right to Buy) |